NEOG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Neogen Corp (NEOG) is not a strong buy for a beginner, long-term investor at this moment. While hedge funds are increasing their positions and analysts have raised price targets, the company's financial performance is weak, with significant YoY declines in revenue, net income, and EPS. Additionally, technical indicators suggest a potential short-term downside, and there are no strong proprietary trading signals to support immediate action. It is better to monitor the stock for improved financial performance or stronger technical signals before investing.
The MACD is negatively expanding, indicating bearish momentum. RSI is neutral at 75.298, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading near resistance levels (R1: 10.878), and candlestick pattern analysis suggests an 80% probability of short-term declines (-0.65% in the next day, -3.46% in the next week, -12.22% in the next month).
Hedge funds are significantly increasing their positions, with a 999.08% increase in buying over the last quarter. Analysts have raised price targets and upgraded ratings, citing improved portfolio performance and cost actions taking effect.
The company's financials for 2026/Q2 show significant YoY declines in revenue (-2.84%), net income (-96.51%), and EPS (-96.67%). Gross margin also dropped to 37.29%. No recent news or congress trading data to provide additional support.
In 2026/Q2, revenue dropped to $224.69M (-2.84% YoY), net income fell to -$15.92M (-96.51% YoY), EPS declined to -$0.07 (-96.67% YoY), and gross margin decreased to 37.29% (-3.89% YoY).
Guggenheim raised the price target to $12 from $8 and maintained a Buy rating, citing improved portfolio performance and cost actions. CJS Securities upgraded the stock to Outperform with a $10 price target. Analysts are cautiously optimistic but acknowledge that one quarter does not establish a trend.
